Standard

“Doctor as a drug” in a stroke follow-up. / Aleshchenko, E. A.; Kashtalap, V. V.

In: Complex Issues of Cardiovascular Diseases, Vol. 11, No. 1, 11, 2022, p. 107-111.

Research output: Contribution to journal › Review article › peer-review

Harvard

Aleshchenko, EA & Kashtalap, VV 2022, '“Doctor as a drug” in a stroke follow-up', Complex Issues of Cardiovascular Diseases, vol. 11, no. 1, 11, pp. 107-111. https://doi.org/10.17802/2306-1278-2022-11-1-107-111

APA

Aleshchenko, E. A., & Kashtalap, V. V. (2022). “Doctor as a drug” in a stroke follow-up. Complex Issues of Cardiovascular Diseases, 11(1), 107-111. [11]. https://doi.org/10.17802/2306-1278-2022-11-1-107-111

Vancouver

Aleshchenko EA, Kashtalap VV. “Doctor as a drug” in a stroke follow-up. Complex Issues of Cardiovascular Diseases. 2022;11(1):107-111. 11. doi: 10.17802/2306-1278-2022-11-1-107-111

Author

Aleshchenko, E. A. ; Kashtalap, V. V. / “Doctor as a drug” in a stroke follow-up. In: Complex Issues of Cardiovascular Diseases. 2022 ; Vol. 11, No. 1. pp. 107-111.

BibTeX

@article{8189b8b4086c45bfaae1734809eedbe1,
title = "“Doctor as a drug” in a stroke follow-up",
abstract = "Each year about 400 000 people in Russia get strokes. Whereas an acute treatment takes place in specialized intensive care units in hospitals, follow-up is handed over to general (rarely – private) practitioner. The majority of stroke survivors show low adherence to follow-up resulting in repeated hospitalizations and growth of multi-morbidity burden. With COVID-19 pandemic negatively affecting availability of medical services and increasing health risks for stroke survivors, a physician-patient relation becomes the means of persuading patients to health-promoting behaviour.",
keywords = "Case management, Follow-up, Physician-patient relation, Stroke survivors",
author = "Aleshchenko, {E. A.} and Kashtalap, {V. V.}",
note = "The article is published within the framework of the main scientific topics of Novosibirsk State University and Federal State Budgetary Scientific Institution «Research Institute for Complex Issues of Cardiovascular Diseases»: No. 0419-2022-0002 Development of innovative models for managing the risk of circulatory diseases taking into account comorbidity based on the study of fundamental, clinical, epidemiological mechanisms and organizational technologies of medical care in the industrial region of Siberia. Publisher Copyright: {\textcopyright} 2022 University of Latvia. All Rights Reserved.",
year = "2022",
doi = "10.17802/2306-1278-2022-11-1-107-111",
language = "English",
volume = "11",
pages = "107--111",
journal = "Комплексные проблемы сердечно-сосудистых заболеваний",
issn = "2306-1278",
publisher = "Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний",
number = "1",

}

RIS

TY - JOUR

T1 - “Doctor as a drug” in a stroke follow-up

AU - Aleshchenko, E. A.

AU - Kashtalap, V. V.

N1 - The article is published within the framework of the main scientific topics of Novosibirsk State University and Federal State Budgetary Scientific Institution «Research Institute for Complex Issues of Cardiovascular Diseases»: No. 0419-2022-0002 Development of innovative models for managing the risk of circulatory diseases taking into account comorbidity based on the study of fundamental, clinical, epidemiological mechanisms and organizational technologies of medical care in the industrial region of Siberia. Publisher Copyright: © 2022 University of Latvia. All Rights Reserved.

PY - 2022

Y1 - 2022

N2 - Each year about 400 000 people in Russia get strokes. Whereas an acute treatment takes place in specialized intensive care units in hospitals, follow-up is handed over to general (rarely – private) practitioner. The majority of stroke survivors show low adherence to follow-up resulting in repeated hospitalizations and growth of multi-morbidity burden. With COVID-19 pandemic negatively affecting availability of medical services and increasing health risks for stroke survivors, a physician-patient relation becomes the means of persuading patients to health-promoting behaviour.

AB - Each year about 400 000 people in Russia get strokes. Whereas an acute treatment takes place in specialized intensive care units in hospitals, follow-up is handed over to general (rarely – private) practitioner. The majority of stroke survivors show low adherence to follow-up resulting in repeated hospitalizations and growth of multi-morbidity burden. With COVID-19 pandemic negatively affecting availability of medical services and increasing health risks for stroke survivors, a physician-patient relation becomes the means of persuading patients to health-promoting behaviour.

KW - Case management

KW - Follow-up

KW - Physician-patient relation

KW - Stroke survivors

UR - http://www.scopus.com/inward/record.url?scp=85136524276&partnerID=8YFLogxK

UR - https://elibrary.ru/item.asp?id=48231676

UR - https://www.mendeley.com/catalogue/796076d8-ad43-3df5-b56d-e3cc04f1b661/

U2 - 10.17802/2306-1278-2022-11-1-107-111

DO - 10.17802/2306-1278-2022-11-1-107-111

M3 - Review article

AN - SCOPUS:85136524276

VL - 11

SP - 107

EP - 111

JO - Комплексные проблемы сердечно-сосудистых заболеваний

JF - Комплексные проблемы сердечно-сосудистых заболеваний

SN - 2306-1278

IS - 1

M1 - 11

ER -

ID: 37053458